MarketLens
Sign Up

Is Biogen (BIIB) a Buy, Hold, or Sell Right Now

7 months ago
SHARE THIS ON:

Is Biogen (BIIB) a Buy, Hold, or Sell Right Now

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 months ago

Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report?

Biogen (BIIB) may beat estimates in its next quarterly report, supported by its earnings surprise history and a favorable combination of two key ingredients.
Stock News•2 months ago

Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month?

Biogen (BIIB) rose 9% in a month, driven by newer drugs, M&A, and pipeline progress, though declining multiple sclerosis sales remain a key risk to the turnaround.
Stock News•4 months ago

This Biogen Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Biogen received a bullish analyst upgrade Monday, among the top five analyst rating changes. The upgrade reflects improved outlook for the company's pipeline or commercial prospects.

Breaking News

View All →

Top Headlines

View More →
Stock News•1 hour ago

An Nvidia engineer says he's quitting because Jensen Huang was ousted: 'So disappointing'

Stock News•2 hours ago

Is bad news for Jensen Huang also bad news for the AI industry?

Stock News•2 hours ago

Amazon loses 40 Leo satellites in ULA Vulcan launch failure — a new setback for its Starlink rival

Stock News•2 hours ago

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NVIDIA Corporation Investors with Losses in Excess of $500k to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NVDA

Stock News•3 hours ago

Nvidia CEO Jensen Huang Resigns as Stock Tanks. Here Are the Next Steps for Investors.